These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 19534681)

  • 1. Efficacy of curcuminoids in alleviation of iron overload and lipid peroxidation in thalassemic mice.
    Thephinlap C; Phisalaphong C; Fucharoen S; Porter JB; Srichairatanakool S
    Med Chem; 2009 Sep; 5(5):474-82. PubMed ID: 19534681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of cardiac iron loading and dysfunction in thalassemic mice by curcuminoids.
    Thephinlap C; Phisalaphong C; Lailerd N; Chattipakorn N; Winichagoon P; Vadolas J; Fucharoen S; Porter JB; Srichairatanakool S
    Med Chem; 2011 Jan; 7(1):62-9. PubMed ID: 21235521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Green tea extract modulates oxidative tissue injury in beta-thalassemic mice by chelation of redox iron and inhibition of lipid peroxidation.
    Koonyosying P; Kongkarnka S; Uthaipibull C; Svasti S; Fucharoen S; Srichairatanakool S
    Biomed Pharmacother; 2018 Dec; 108():1694-1702. PubMed ID: 30372872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin contributes to in vitro removal of non-transferrin bound iron by deferiprone and desferrioxamine in thalassemic plasma.
    Srichairatanakool S; Thephinlap C; Phisalaphong C; Porter JB; Fucharoen S
    Med Chem; 2007 Sep; 3(5):469-74. PubMed ID: 17897073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of green tea on iron accumulation and oxidative stress in livers of iron-challenged thalassemic mice.
    Saewong T; Ounjaijean S; Mundee Y; Pattanapanyasat K; Fucharoen S; Porter JB; Srichairatanakool S
    Med Chem; 2010 Mar; 6(2):57-64. PubMed ID: 20218965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consumption of a green tea extract-curcumin drink decreases blood urea nitrogen and redox iron in β-thalassemia patients.
    Koonyosying P; Tantiworawit A; Hantrakool S; Utama-Ang N; Cresswell M; Fucharoen S; Porter JB; Srichairatanakool S
    Food Funct; 2020 Jan; 11(1):932-943. PubMed ID: 31950948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron-chelating and free-radical scavenging activities of microwave-processed green tea in iron overload.
    Srichairatanakool S; Ounjaijean S; Thephinlap C; Khansuwan U; Phisalpong C; Fucharoen S
    Hemoglobin; 2006; 30(2):311-27. PubMed ID: 16798656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms for the shuttling of plasma non-transferrin-bound iron (NTBI) onto deferoxamine by deferiprone.
    Evans P; Kayyali R; Hider RC; Eccleston J; Porter JB
    Transl Res; 2010 Aug; 156(2):55-67. PubMed ID: 20627190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron distribution and histopathological characterization of the liver and heart of β-thalassemic mice with parenteral iron overload: Effects of deferoxamine and deferiprone.
    Yatmark P; Morales NP; Chaisri U; Wichaiyo S; Hemstapat W; Srichairatanakool S; Svasti S; Fucharoen S
    Exp Toxicol Pathol; 2014 Sep; 66(7):333-43. PubMed ID: 24907196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-type calcium channel blockade improves survival and cardiovascular function in thalassemic mice.
    Kumfu S; Chattipakorn S; Chinda K; Fucharoen S; Chattipakorn N
    Eur J Haematol; 2012 Jun; 88(6):535-48. PubMed ID: 22404220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of vitamin C as an adjuvant therapy to different iron chelators in young β-thalassemia major patients: efficacy and safety in relation to tissue iron overload.
    Elalfy MS; Saber MM; Adly AA; Ismail EA; Tarif M; Ibrahim F; Elalfy OM
    Eur J Haematol; 2016 Mar; 96(3):318-26. PubMed ID: 26018112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of deferasirox and deferoxamine in clinical practice: an alternative scheme of chelation in thalassemia major patients.
    Cassinerio E; Orofino N; Roghi A; Duca L; Poggiali E; Fraquelli M; Zanaboni L; Cappellini MD
    Blood Cells Mol Dis; 2014 Sep; 53(3):164-7. PubMed ID: 24846580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A combination of an iron chelator with an antioxidant exerts greater efficacy on cardioprotection than monotherapy in iron-overload thalassemic mice.
    Kumfu S; Khamseekaew J; Palee S; Srichairatanakool S; Fucharoen S; Chattipakorn SC; Chattipakorn N
    Free Radic Res; 2018 Jan; 52(1):70-79. PubMed ID: 29207893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigallocatechin-3-gallate and epicatechin-3-gallate from green tea decrease plasma non-transferrin bound iron and erythrocyte oxidative stress.
    Thephinlap C; Ounjaijean S; Khansuwan U; Fucharoen S; Porter JB; Srichairatanakool S
    Med Chem; 2007 May; 3(3):289-96. PubMed ID: 17504202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The deferiprone and deferasirox combination is efficacious in iron overloaded patients with β-thalassemia major: A prospective, single center, open-label study.
    Totadri S; Bansal D; Bhatia P; Attri SV; Trehan A; Marwaha RK
    Pediatr Blood Cancer; 2015 Sep; 62(9):1592-6. PubMed ID: 25820920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the safety and efficacy of silymarin in β-thalassemia patients: a review.
    Moayedi Esfahani BA; Reisi N; Mirmoghtadaei M
    Hemoglobin; 2015; 39(2):75-80. PubMed ID: 25643967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the iron chelator deferiprone and the T-type calcium channel blocker efonidipine on cardiac function and Ca
    Khamseekaew J; Kumfu S; Palee S; Wongjaikam S; Srichairatanakool S; Fucharoen S; Chattipakorn SC; Chattipakorn N
    Cell Calcium; 2018 Jun; 72():18-25. PubMed ID: 29748130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-utility analysis of deferiprone for the treatment of β-thalassaemia patients with chronic iron overload: a UK perspective.
    Bentley A; Gillard S; Spino M; Connelly J; Tricta F
    Pharmacoeconomics; 2013 Sep; 31(9):807-22. PubMed ID: 23868464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum non-transferrin-bound iron in beta-thalassaemia major patients treated with desferrioxamine and L1.
    al-Refaie FN; Wickens DG; Wonke B; Kontoghiorghes GJ; Hoffbrand AV
    Br J Haematol; 1992 Oct; 82(2):431-6. PubMed ID: 1419825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Iron Chelators on Pulmonary Iron Overload and Oxidative Stress in β-Thalassemic Mice.
    Yatmark P; Morales NP; Chaisri U; Wichaiyo S; Hemstapat W; Srichairatanakool S; Svasti S; Fucharoen S
    Pharmacology; 2015; 96(3-4):192-9. PubMed ID: 26316149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.